Genmab A (GMAB) Current Leases (2019 - 2026)

Genmab A has reported Current Leases for 6 years, with the latest figure at $125.0 million in Q1 2026.

• For the quarter ending Q1 2026, Current Leases fell 3.1% year-over-year to $125.0 million; the trailing twelve-month figure through Mar 2026 stood at $125.0 million (down 3.1% YoY), and the FY2025 full-year result was $134.0 million, up 930.77% from the prior year.
• Current Leases for Q1 2026 stood at $125.0 million, down from $134.0 million in the prior quarter.
• The five-year high for Current Leases was $134.0 million in Q4 2025, with the low at $13.0 million in Q4 2023.
• Historically, Current Leases has averaged $96.0 million across 4 years, with a median of $126.0 million in 2025.
• Annual changes were most pronounced in 2025 — Current Leases surged 930.77% — and 2026, when it decreased 3.1%.
• Genmab A's Current Leases stood at $13.0 million in 2023, then changed by 0.0% to $13.0 million in 2024, then surged by 930.77% to $134.0 million in 2025, then fell by 6.72% to $125.0 million in 2026.
• The last three Current Leases figures came in at $125.0 million (Q1 2026), $134.0 million (Q4 2025), and $126.0 million (Q3 2025), per Business Quant data.